Pakistan Pharmas Say Exports In Decline Because Of Government Policies
This article was originally published in PharmAsia News
An organization of Pakistan's drug makers complains its members are experiencing a serious decline in exports because of the policies of the Drug Regulatory Authority of Pakistan.
You may also be interested in...
A draft guidance document by the US FDA that tackles medical device cybersecurity will likely be issued in the next several months, says Linda Ricci, a health scientist for the agency’s Office of Device Evaluation. Check out her comments on cybersecurity here.
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.